破裂与未破裂梭形脑动脉瘤的显微外科治疗技术与结局
该回顾性研究分析了45例患者共48个梭形动脉瘤的显微外科治疗技术与结局,其中12例(27%)为破裂动脉瘤,33例(73%)为未破裂动脉瘤。动脉瘤平均大小8.9 mm,采用夹闭重建(22个,46%)、夹闭包裹(18个,38%)和血管搭桥(8个,17%)治疗。随访期间无再出血,总体年复发风险为2%,年再出血风险为0%。
要点
- 45例患者共48个梭形动脉瘤,破裂12例(27%),未破裂33例(73%)。
- 治疗方式包括夹闭重建22个(46%)、夹闭包裹18个(38%)、血管搭桥8个(17%)。
- 随访期间无再出血,总体年复发风险2%,年再出血风险0%。
核心结论
- 累及整个血管壁的梭形和扩张性动脉瘤必须个体化评估。
- 尽管部分动脉瘤可能适合直接夹闭和夹闭重建,这些复杂病变常需要替代的显微外科和血管内治疗。
- 这些技术可以在可接受的致残率和死亡率下实施,且早期再出血和复发率低。
研究设计与样本
- 回顾性研究,纳入45例梭形动脉瘤患者,共治疗48个梭形动脉瘤;患者平均年龄49岁(中位51岁,范围6个月至76岁),其中男性18例、女性27例。
主要发现
- 12例患者(27%)为破裂动脉瘤,33例(73%)为未破裂动脉瘤;动脉瘤平均大小8.9 mm(范围6-28 mm)。
- 动脉瘤治疗方式:夹闭重建22个(46%),夹闭包裹18个(38%),血管搭桥8个(17%)。
- 12例蛛网膜下腔出血患者平均住院时间19.0±7.4天,33例未破裂动脉瘤患者平均住院时间7.0±5.6天。
- 平均随访38.7±29.5个月(中位36个月,范围6-96个月);12例蛛网膜下腔出血患者平均格拉斯哥结局量表评分为3.9,33例未破裂动脉瘤患者为4.8。
- 随访期间无再出血;总体年复发风险为2%,年再出血风险为0%。
临床怎么用
- 作者认为,累及整个血管壁的梭形和扩张性动脉瘤必须个体化评估,部分可能适合直接夹闭和夹闭重建,但常需要替代的显微外科和血管内治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Fusiform cerebral aneurysms represent a small portion of intracranial aneurysms; differ in natural history, anatomy, and pathology; and can be difficult to treat compared with saccular aneurysms. The purpose of this study was to examine the techniques of treatment of ruptured and unruptured fusiform intracranial aneurysms and patient outcomes. METHODS In 45 patients with fusiform aneurysms, the authors retrospectively reviewed the presentation, location, and shape of the aneurysm; the microsurgical technique; the outcome at discharge and last follow-up; and the change in the aneurysm at last angiographic follow-up. RESULTS Overall, 48 fusiform aneurysms were treated in 45 patients (18 male, 27 female) with a mean age of 49 years (median 51 years; range 6 months-76 years). Twelve patients (27%) had ruptured aneurysms and 33 (73%) had unruptured aneurysms. The mean aneurysm size was 8.9 mm (range 6-28 mm). The aneurysms were treated by clip reconstruction (n = 22 [46%]), clip-wrapping (n = 18 [38%]), and vascular bypass (n = 8 [17%]). The mean (SD) hospital stay was 19.0 ± 7.4 days for the 12 patients with subarachnoid hemorrhage and 7.0 ± 5.6 days for the 33 patients with unruptured aneurysms. The mean follow-up was 38.7 ± 29.5 months (median 36 months; range 6-96 months). The mean Glasgow Outcome Scale score for the 12 patients with subarachnoid hemorrhage was 3.9; for the 33 patients with unruptured aneurysms, it was 4.8. No rehemorrhages occurred during follow-up. The overall annual risk of recurrence was 2% and that of rehemorrhage was 0%. CONCLUSIONS Fusiform and dolichoectatic aneurysms involving the entire vessel wall must be investigated individually. Although some of these aneurysms may be amenable to primary clipping and clip reconstruction, these complex lesions often require alternative microsurgical and endovascular treatment. These techniques can be performed with acceptable morbidity and mortality rates and with low rates of early rebleeding and recurrence.
引用
- Safavi-Abbasi S, Kalani MYS, Frock B, et al. Techniques and outcomes of microsurgical management of ruptured and unruptured fusiform cerebral aneurysms. J Neurosurg. 2017. PMID: 28186451. doi:10.3171/2016.9.JNS161165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。